FILIPPO DE MARINIS EUROPEAN INSTITUTE OF ONCOLOGY (IEO), VIA RIPAMONTI 435, 20141, MILAN IT
|
|
- Herbert Roberts
- 7 years ago
- Views:
Transcription
1 E U R O P E A N C U R R I C U L U M V I T A E F O R M A T PERSONAL INFORMATION Name Address FILIPPO DE MARINIS Phone Fax Mobile EUROPEAN INSTITUTE OF ONCOLOGY (IEO), VIA RIPAMONTI 435, 20141, MILAN IT Web site demarinis.filippo@virgilio.it filippo.demarinis@ieo.it demarinis.filippo@gmail.com Nationality Italian Date of birth 24/04/1952 WORK EXPERIENCE Dates (from to) FROM NOVEMBER 2013 AND AT PRESENT European Institute of Oncology (IEO), via Ripamonti 435, Milan IT Thoracic Oncology Division, DIRECTOR. FROM 2000 TO OCTOBER 2013 San Camillo & Forlanini Hospitals, Circonvallazione Gianicolense, Rome IT High Specialization Hospital Lung Disease Director 1 st Oncological Pulmonary Unit Page 1 - Curriculum vitae of
2 responsibilities Management, therapeutical decision, human resources coordination and financial budget building. The U.O.C. is consisting of: Ordinary stay in Hospital n.10 beds e n.10 beds in Day Hospital Staff with n. 4 MD of 1st level, n. 1 MD at contract, n.3 fellowships, n. 1 data-manager as fellowships, n. 2 ward sisters, n. 18 nurses and n.2 helpers plus Outpatients Dpt. Dates (from to) responsibilities From 2007 to 2012 and at present 1 st University of Rome La Sapienza, P.le Aldo Moro 5, Rome IT Postgraduate School Professor in Oncology Teaching, training and education Dates (from to) From 2007 to 2010 Private University of Rome Campus Biomedico, Via E. Longoni 83, Rome IT Postgraduate School Professor in Oncology Teaching, training and education responsibilities Page 2 - Curriculum vitae of
3 Date (from to) From January 30th 1998 to August 2000 Carlo Forlanini Hospital, P.le Carlo Forlanini 1, Rome IT Hospital Dpt. - 5 Operative Unit in Oncological Pulmonary Executive Manager Ordinary stay in Hospital n. 40 beds ande n. 10 beds in Day Hospital responsabilities Staff with n. 7 MD of 1st level, n. 1 ward sister, n. 18 nurses and n. 2 helpers Date (from to) From 1996 to 1998 Biomedical Sciences and Oncology Superior School Rome and Cagliari Parallel Courses Occupation or postion held Teacher Teaching, training and education responsabilities Date (from to) FROM APRIL 06 TH 1995 TO JANUARY 30 TH 1998 Carlo Forlanini Hospital, P.le Carlo Forlanini 1, Rome IT Hospital Dpt. - 3^ Pneumological Division Responsable of Modulo Funzionale A Sector - 1st level of Managing in health role responsabilities Activities of extremely high dose chemotherapy in thoracic tumors of functional area of medicine, new drugs testing. Responsibility of treatment and clinical course of patients hospital admission for pulmonary tumors with control of collateral effects. Dates (from to) From 1993 to 1996 Prof. J. P. Kleisbauer Marseille University - FR Clinical Studies Institute and Pneumopthisiological Researches Professor Teaching, training and education responsibilities Dates (from to) FROM FEBRUARY 16TH 1991 TO 1995 Carlo Forlanini Hospital, P.le Carlo Forlanini 1, Rome IT Hospital Dpt. 3^ Pneumological Division Special Assistant of Pneumology in role, competitive examination, in USL RM/10 responsibilities Oncological Day-Hospital and Home Care Service in patients with respiratory insufficiency in continuation oxygen-therapy. Responsable of n^ 6 beds for diagnostic-therapeutical activity and daily clinic of Hospital Stay Dates (from to) FROM 1990 Ministry of Health Forensic Medicine Office Consultant for Pneumology in medical colleges responsibilities Forensic Medicine advices Dates (from to) FROM 01/11/1987 TO 1991 Carlo Forlanini Hospital, P.le Carlo Forlanini 1, Rome Hospital Dpt. 3^ Pneumological Division Pneumological Assistant non in role, winner of internal announcement responsibilities Page 3 - Curriculum vitae of
4 Dates (from to) FROM 1987 TO 1999 S.M.O.R.R.L. - Rome and Lazio Hospital Medical School Teacher responsibilities Teaching, training and education Dates (from to) FROM 1985 TO 1989 Professional Nurses School Carlo Forlanini Hospital in Rome Teacher responsibilities Teaching in Social Medicine Dates (from to responsibilities FROM 1984 TO 1991 Agreement between 1 University La Sapienza Rome and USL RM/10 3^ Pneumological Division of Carlo Forlanini Hospital At first, Assistant in Pulmonary and after Special Assistant MD for sanitary-organizing activities in assistance, teaching and research Dates (from to responsibilities Prof. F. Cavalli SAKK Ticinese Section Oncology Division San Giovanni Bellinzona Hospital Theoretical and pratical trainee Phase II clinical studies in antineoplastic new drugs From April 1st to April 30th 1982 Dates (from to) FROM APRIL 17 TH 1980 TO 1991 Winner of public announcement Employee with deliberation on 04/17/80 and from 09/01/1980 employeer in full time Monteverde Hosp-Sanitary Section Pneumology Assistant responsibilities MD for sanitary-organizing activities in assistance, teaching and research Dates (from to) FROM APRIL 1979 TO JULY 1980 Page 4 - Curriculum vitae of
5 responsibilities Due for call-up in Army 8^ ORME of Rome Sanitary Service Manager Voluntary worker in 3^ Division of Pneumology Forlanini Hospital Dates (from to) FROM 1977 TO 1978 Carlo Forlanini Hospital, Ple Forlanini 1, Rome IT 3 Division of Pneumology Trainee responsibilities EDUCATION AND TRAINING Dates (from to) From ^ European Conference on Clinical Oncology ESMO, London Oncology European Oncologist Dates (from to) From April 1989 Carlo Forlanini Hospital, P.le Carlo Forlanini 1, Rome IT Pneumology Pneumologist Director Dates (from to) From November 1983 to July nd University of Rome Cattolica del Sacro Cuore Specialization High School in Oncology Experimental thesis on Clinical aspects of bone metastasis from primitive lung carcinoma - edited for printing paper SPECIALIZATION in Oncology Dates (from to) From November 1978 to July st University of Rome La Sapienza Specialization High School in Lung Diseases Experimental thesis on Polichemotherapy in the treatment of primitive lung carcinoma at III stady not surgical operable: analysis of secondary toxicity immediate and delayed referring the response and the survival SPECIALIZATION in Pneumology Page 5 - Curriculum vitae of
6 Dates (from to) From April 14 th st University of Rome La Sapienza The Medical and Surgery Faculty Pthsiology Experimental graduation thesis on Chronic bronchitis and allergies Dates (from to) From 1969 Italian Secondary School Virgilio - Rome IT Classical Studies School Leaving taken after five years of Liceo Page 6 - Curriculum vitae of
7 PERSONAL SKILLS Acquired in the course of life and career but not necessarily covered by formal certificates and diplomas. MOTHER TONGUE ITALIAN LANGUAGE OTHER LANGUAGES ENGLISH AND FRENCH LANGUAGE Reading skills Good Good Writing skills Good Good Verbal skills Good Good SOCIAL SKILLS Living and working with other people, in multicultural environments, in positions where communication is important and situations where teamwork is essential (for example culture and sports), etc. ORGANISATIONAL SKILLS Coordination and administration of people, projects and budgets; at work, in voluntary work (for example culture and sports) and at home, etc. TECHNICAL SKILLS With computers, specific kinds of equipment, machinery, etc. ARTISTIC SKILLS Music, writing, design, etc. OTHER SKILLS Competences not mentioned above. DAILY CLINICAL ACTIVITY IN MULTIDISCIPLINARY EQUIPE PARTECIPATION IN WORKING NATIONAL AND INTERNATIONAL GROUPS (ADVISORY BOARD, INVESTIGATOR MEETING. ETC.) AT PRESENT MEMBER OF THE ETHICAL COMMITTEE OF SAN CAMILLO FORLANINI HOSPITALS. MEMBER OF THE ETHICAL COMMITTEE OF SANT'ANDREA HOSPITAL AND REGINA ELENA NATIONAL INSTITUTE AGAINST CANCER IN THE PAST ROME IT MEMBER OF SCIENTIFIC ITALIAN AND INTERNATIONAL ASSOCIATIONS WITH ACTIVE ROLES: AIOT, ITALIAN THORACIC ONCOLOGY (PRESIDENT 2007/2012 PAST PRESIDENT FROM 2012), ESMO (FACULTY MEMBER FOR CHEST TUMORS 2010/2014), ETOP, EUROPEAN ONCOLOGICAL RESEARCH (MEMBER OF WORKING GROUP ACTIVITIES IN THE WEB), ASCO AND IASLC (MEMBER) AIOM, ITALIAN MEDICAL ONCOLOGY (CONSELLOR OF BOARD OF DIRECTORS 2003/2005 E 2005/2007 REGIONAL CONSELLOR 1991/1995, SECRETARY- TREASURER 1995/2000, REGIONAL PRESIDENT 2001/2003), SIMER, ITALIAN RESPIRATORY MEDICINE (MEMBER AND RESPONSABLE FOR THORACIC ONCOLOGY GROUP 1994/1996), AIPO, ITALIAN HOSPITAL PNEUMOLOGISTS (PROMOTER 1990, SECRETARY-TREASURER 1990/1996, FONICAP (REGIONAL CONSELLOR 1991/1994), AIMAR (SCIENTIFIC COMMITTEE MEMBER OF ONCOLOGY OFFICIAL JOURNAL MRM) EXCELLENT CAPACITIES OF ORGANIZATION, COORDINATION, MANAGEMENT AND RUNNING OF HUMAN MEDICAL RESOURCES WARD ACTIVITIES, DAY HOSPITAL AND CLINICAL ACTIVITY. EXCELLENT ABILITY ABOUT FINANCIAL MANAGEMENT AND BALANCE&BUDGET DRAWING UP. SPECIFIC COMPETENCE IN SCIENTIFIC EVENTS ORGANIZATION AND IN BUILDING UP EDUCATIONAL PROGRAMMES AND IN OUTLINING AND COORDINATING PEOPLE AS SPEAKERS AND TEACHERS. EXCELLENT ABILITY IN THE USE OF COMPUTER FOR WORD PROGRAMME AND ABOVEALL SPECIFIC AND VERY HIGH COMPETENCE AND KNOLEDGE FOR USING POWER POINT PROGRAMME ALSO IN CREATIVE WAY. EXCELLENT ABILITY IN SURFING AND IN DISCOVERING ITS NEW ELEMENTS. A GOOD KNOWLEDGE AND COMPETENCE IN USING REPRODUCTION MUSICAL PROGRAMME AND BUILDING VIDEOS (WINDOWS MOVIE MAKER). THESE ACTIVITIES HAVE BEEN DOING BOTH IN PROFESSIONAL AND PRIVATE FIELD. GOOD ARTISTIC ABILITY IN PLAYING MUSIC WITH DRUMS AS AN AMATEUR. Excellent sports abilities and competences in sailing acquired in a competitive past during many races in Italian Country with the acquisition of Italian champion titles. Page 7 - Curriculum vitae of
8 DRIVING LICENCE(S) A and B ADDITIONAL INFORMATION In the past Scientific Consultant of many Pharmaceutical Companies: Eli Lilly, Astrazeneca, Sanofi-Aventis. At the present for Roche, and Boehringer Ingelheim In the last 5 years ( ) Invited Speaker in more than 300 scientific meetings (80% as Speaker and 20% as Chair), whose in 20% of cases took part in Scientific Committee (60 meetings/year). Participation in 40 Advisory Boards and in 17 Investigator Meetings as Speaker. About scientific international activities in the last 5 years ( ) invited Speaker in 50 International Meetings (10% as chair). Expert in Good Clinical Practice Trials on New Antineoplastic Drugs in Lung Cancer (phase I, II, III) and developer trials in Lung Cancer with Vinorelbine, Paclitaxel, Docetaxel, Gemcitabine, Topotecan, Pemetrexed, Affinitak, MMPI, SR 48692, Gefitinib, Erlotinib, Cetuximab, BMS , Bevacizumab, Sorafenib, Sunitinib, ASA 404, Zoledronic Acid, Bortezomib, Vandetanib, Vargatef, Amrubicin, Vorinostat, Panobinostat, CPT-751, Talactoferrin, Eribulin Mesylate, MAGE-3, Stimuvax, Afatinib, Onartuzumab, Ramucirumab, Crizotinib, Dacomitinib, Tivantinib, etc. In the last 5 years ( ) participation in more than 80 clinical studies controlled in phase I-II-III as Principal Investigators (20 new studies/year) recruiting about 80 patients/year (20% Annual casistic) Authors of more than 250 printed scientific publications (14 books/monographers and 125 papers in International Indexed Reviews on PUB MED) Impact Factor di: cp=re214_x_p2&ch=reg&login=demarinis.filippo@virgilio.it&pli=1 Citation Index of: 8444 on 100 pubblications (Hirsch s Index: 37) Page 8 - Curriculum vitae of
9 Associate Editor in Lung Cancer for a term of two years (1 June 2011/2013) Reviewer in charge of more than 36 Scientific National and International Journals: Annals of Oncology, Aging Health, Cancer Therapy, Cancer Chemotherapy and Pharmacology, Lung Cancer, Current Pharmacogenomics, Clinical Medicine Insights: Oncology, Clinical Revue in Oncology and Hematology, Clinical Lung Cancer, Cancer Treatment Revue, Chemotherapy, Cancer Investigation, Cancer Therapy, Current Pharmacogenomics, Journal of Medical Economics, CML Lung Cancer, Current Gerontology & Geriatrics Research, Current Opinion in Oncology, Current Stem Cell Research, European Oncology, Expert Review of Anticancer Therapy, Expert Review of Clinical Pharmacology, Frontiers in Drugs Design and Discovery, Future Oncology, International Journal of Biomedical Sciences, Journal of chinese Clinical Medicine, Lung Cancer Target and Therapy, Oncology, The Oncologist, Respiration, Therapeutics and Clinical Risk Management, Therapeutic Advances in Medical Oncology. ANNEXES About publications please look up website pointed here below http// Milan, November 11 th 2013 Page 9 - Curriculum vitae of
Thoracic Oncology Unit
F ORMATO EUROPEO PER IL CURRICULUM VITAE PERSONAL INFORMATION Name NOVELLO Silvia Address AOU S Luigi Gonzaga, Regione Gonzole 10, 10043 Orbassano, Torino Telephone +39-011-9026978 Fax +39-011-9038616
More informationGIORGIO VITTORIO SCAGLIOTTI, M.D. CURRICULUM VITAE
GIORGIO VITTORIO SCAGLIOTTI, M.D. CURRICULUM VITAE Personal Information Date of birth July 2, 1953 Place of birth Torino, Italy Office address Department of Oncology S. Luigi Gonzaga Hospital, Oncology
More informationE UROPEAN C URRICULUM V ITAE F ORMAT
E UROPEAN C URRICULUM V ITAE F ORMAT PERSONAL INFORMATION Name LOZZA LAURA Telephone 39-02-23902480 Fax 39-02-23902472 E-mail laura.lozza@istitutotumori.mi.it Nationality Italian Date of Birth 23.01.1960
More informationE UROPEAN CURRICULUM VITAE FORMAT
E UROPEAN CURRICULUM VITAE FORMAT PERSONAL INFORMATION Name Address VALENTINA GUARNERI University of Padova Dipartimento di Scienze Chirurgiche, Oncologiche e Gastroenterologiche Istituto Oncologico Veneto
More informationKOL Insight: Non-small cell lung cancer Game changing immunotherapies to revolutionise treatment
March 2014 KOL Insight: Non-small cell lung cancer A FirstWord Therapy Trends Report KOL Insight: Lung Cancer Published March 2014 Copyright 2014 Doctor s Guide Publishing Limited All rights reserved.
More informationELCC 2015 Industry Satellite Symposium The Treatment Roadmap for Squamous NSCLC. Thursday 16th April 2015 13:10 14:20 Room C
ELCC 2015 Industry Satellite Symposium The Treatment Roadmap for Squamous NSCLC Thursday 16th April 2015 13:10 14:20 Room C 1 Contents Programme.... 2 Welcome message.... 3 Faculty biographies.... 4 Symposium
More informationUNIVERSITA CATTOLICA DEL SACRO CUORE POLICLINICO UNIVERSITARIO A.GEMELLI CLINICA UROLOGICA Largo F. Vito, 1 00168 Roma, Italy
E UROPEAN CURRICULUM VITAE FORMAT PERSONAL INFORMATION Name BASSI PIERFRANCESCO Address UNIVERSITA CATTOLICA DEL SACRO CUORE POLICLINICO UNIVERSITARIO A.GEMELLI CLINICA UROLOGICA Largo F. Vito, 1 00168
More informationBritish Thoracic Oncology Group (BTOG) Annual Report - April 2014 to March 2015
0116 250 2811 dawn.mckinley@uhl-tr.nhs.uk www.btog.org @BTOGORG British Thoracic Oncology Group (BTOG) Annual Report - April 2014 to March 2015 BTOG s Aim BTOG is the multi-disciplinary group for professionals
More informationInternational MD Program
International MD Program A. Gemelli School of Medicine A.Y. 2013/2014 Rome Campus The City of Rome Roma caput mundi Rome was founded on 21 April 753 B.C. and since then the City has always played a crucial
More informationE UROPEAN PERSONAL INFORMATION
E UROPEAN CURRICULUM VITAE FORMAT PERSONAL INFORMATION Name Work Address ARTURO CHITI Humanitas University, Via A. Manzoni 113, 20089 Rozzano (MI), Italy Nuclear Medicine Department, Humanitas Research
More informationAvastin in breast cancer: Summary of clinical data
Avastin in breast cancer: Summary of clinical data Worldwide, over one million people are diagnosed with breast cancer every year 1. It is the most frequently diagnosed cancer in women 1,2, and the leading
More informationJourney in the Academic and Research world of Italy Anna Maria Fioretti
Journey in the Academic and Research world of Italy Anna Maria Fioretti The Regina Elena National Cancer Institute (I.R.E.) part of the Italian network of the LR. C CS. (Istituti di Ricovero e Cura a Carattere
More informationFuture Directions in Clinical Research. Karen Kelly, MD Associate Director for Clinical Research UC Davis Cancer Center
Future Directions in Clinical Research Karen Kelly, MD Associate Director for Clinical Research UC Davis Cancer Center Outline 1. Status of Cancer Treatment 2. Overview of Clinical Research at UCDCC 3.
More informationGabriele Giovanni MESSINA
Gabriele Giovanni MESSINA Curriculum Vitae NAME and FAMILY NAME Gabriele MESSINA NATIONALITY Italian PALCE AND DATE OF BIRTH Ragusa (RG),19 th of march 1973 PROFESSIONAL POSITION Research Professor of
More informationDR. MARIO RAMPA. Instructor at Regional course of Early Defibrillation. S.S.U.Em 118, Via dell Eremo, 9-23900 Lecco - Italy
CURRICULUM VITAE DR. MARIO RAMPA PERSONALINFORMATION Name Address Phone Mario Rampa E-mail Nationality Date of birth Italian June 22 nd, 1979 WORK EXPERIENCE From 01/2001 to 07/2006 General Surgery III
More informationSYSTEMIC THERAPY FOR STAGE IV NON-SMALL CELL LUNG CANCER: AMERICAN SOCIETY OF CLINICAL ONCOLOGY CLINICAL PRACTICE GUIDELINE UPDATE
Which patients with stage IV NSCLC should be treated with chemotherapy? NSCLC with nonsquamous cell carcinoma, negative or unknown EGFR-sensitizing mutation and ALK gene rearrangement status, and PS 0-1
More informationHarmesh Naik, MD. Hope Cancer Clinic HOW DO I MANAGE STAGE 4 NSCLC IN 2012: STATE OF THE ART
Harmesh Naik, MD. Hope Cancer Clinic HOW DO I MANAGE STAGE 4 NSCLC IN 2012: STATE OF THE ART Goals Discuss treatment options for stage 4 lung cancer: New and old Discuss new developments in personalized
More informationMaintenance therapy in in Metastatic NSCLC. Dr Amit Joshi Associate Professor Dept. Of Medical Oncology Tata Memorial Centre Mumbai
Maintenance therapy in in Metastatic NSCLC Dr Amit Joshi Associate Professor Dept. Of Medical Oncology Tata Memorial Centre Mumbai Definition of Maintenance therapy The U.S. National Cancer Institute s
More informationSmall cell Lung cancer New Chemotherapy options. Nicolas Mach, MD,PD
Small cell Lung cancer New Chemotherapy options Nicolas Mach, MD,PD > 40 negative Phase III trials List of unsucessful drugs Pemetrexed, imatinib, bevacizumab, bcl-2 antagonist, ASCT, CASE PRESENTATION
More informationClinician Investigator Program
Clinician Investigator Program Queen s Clinician Investigator Program: Developing the next Overview The Queen s University Clinician Investigator Program (CIP) is an intensive, research-based postgraduate
More informationNational Horizon Scanning Centre. Vandetanib (Zactima) for advanced or metastatic non-small cell lung cancer. December 2007
Vandetanib (Zactima) for advanced or metastatic non-small cell lung cancer December 2007 This technology summary is based on information available at the time of research and a limited literature search.
More informationWORK EXPERIENCE. Name and address of employer. Occupation PERSONAL INFORMATIONS: a.pullini@ismu.org. March 3, 1944. Date of birth
No C U R R I C U L U M V I T A E PERSONAL INFORMATIONS: Name E-mail PULLINI ARMANDO a.pullini@ismu.org Nationality Date of birth italian March 3, 1944 WORK EXPERIENCE After two brief periods of service,
More informationEUROPEAN CURRICULUM VITAE FORMAT
EUROPEAN CURRICULUM VITAE FORMAT PERSONAL INFORMATION Name BELLATI ANDREA Address Telephone 0248025677 Fax E-mail andrea.bellati@feem.it Nationality Italian Date of birth 01/08/1971 WORK EXPERIENCE Dates
More informationAvastin in breast cancer: Summary of clinical data
Avastin in breast cancer: Summary of clinical data Worldwide, over one million people are diagnosed with breast cancer every year 1. It is the most frequently diagnosed cancer in women 1,2, and the leading
More informationCURRICULUM VITAE. Paul Magnus Schneider, M.D. Professor of Surgery
CURRICULUM VITAE Paul Magnus Schneider, M.D. Professor of Surgery OFFICE Department of Visceral and Transplantation Surgery University Hospital Zurich CH-8008 Zurich Switzerland phone: +41-(0)44-2559723
More informationChapter 7: Lung Cancer
Chapter 7: Lung Cancer Contents Chapter 7: Lung Cancer... 1 Small Cell... 2 Good PS + Limited stage... 2 Cisplatin/etoposide... 2 Concurrent chemotherapy + XRT... 2 Good / Intermediate PS... 2 Carboplatin
More informationREPORT ASCO 2002 ORLANDO : LUNG CANCER Johan F. Vansteenkiste, MD, PhD, Univ. Hospital and Leuven Lung Cancer Group
REPORT ASCO 2002 ORLANDO : LUNG CANCER Johan F. Vansteenkiste, MD, PhD, Univ. Hospital and Leuven Lung Cancer Group In the 2002 edition of the ASCO meeting, a total of 315 abstracts in the field of respiratory
More informationMAURIZIO ALBANO. Main activities and responsibilities Surgical, orthopedic, neurological, first aid emergency
E UROPEAN CURRICULUM VITAE FORMAT PERSONAL INFORMATION Name MAURIZIO ALBANO E-mail maurizioalbano@excite.it Nationality ITALIAN Date of birth 13/08/1958 WORK EXPERIENCE Dates (from-to) 1983-1984 Name and
More informationManagement of stage III A-B of NSCLC. Hamed ALHusaini Medical Oncologist
Management of stage III A-B of NSCLC Hamed ALHusaini Medical Oncologist Global incidence, CA cancer J Clin 2011;61:69-90 Stage III NSCLC Includes heterogeneous group of patients with differences in the
More informationA Career in Pediatric Hematology-Oncology? Think About It...
A Career in Pediatric Hematology-Oncology? Think About It... What does a pediatric hematologist-oncologist do? What kind of training is necessary? Is there a future need for specialists in this area? T
More informationNicole1971nterfree.it. March 2001 up to now Spedali Civili di Brescia, Piazzale Spedali Civili 1, 25128 Brescia
- E UROPEAN CURRICULUM VITAE FORMAT PERSONAL INFORMATION Name LIMONE NICOLE Address VIA TORRICELLA DI SOTTO 137, BRESCIA, ITALY Telephone +393664347851 Fax E-mail Nicole1971nterfree.it Nationality Italian
More informationDEPARTMENT OF HEALTH AND HUMAN SERVICES. Health Resources and Services Administration. Advisory Council on Blood Stem Cell Transplantation
This document is scheduled to be published in the Federal Register on 01/21/2016 and available online at http://federalregister.gov/a/2016-01127, and on FDsys.gov Billing Code 4165-15 DEPARTMENT OF HEALTH
More informationMetastatic Breast Cancer 201. Carolyn B. Hendricks, MD October 29, 2011
Metastatic Breast Cancer 201 Carolyn B. Hendricks, MD October 29, 2011 Overview Is rebiopsy necessary at the time of recurrence or progression of disease? How dose a very aggressive treatment upfront compare
More informationMediterranean School of Oncology
Mediterranean School of Oncology Organized and supported by: CINBO Consorzio Interuniversitario Nazionale per la Bioncologia HIGHLIGHTS IN THE MANAGEMENT OF COLORECTAL CANCER, February 1-2, 2007 Domus
More informationTreatment of Metastatic Non-Small Cell Lung Cancer: A Systematic Review of Comparative Effectiveness and Cost Effectiveness
Treatment of Metastatic Non-Small Cell Lung Cancer: A Systematic Review of Comparative Effectiveness and Cost Effectiveness Investigators: Paul G. Shekelle, MD, PhD, Director Alicia R. Maher, MD Clinical
More informationCURRICULUM VITAE. LEONARDO M. FABBRI Professor of Respiratory Medicine
CURRICULUM VITAE LEONARDO M. FABBRI Professor of Respiratory Medicine Department of Medical and Surgical Specialties Section of Respiratory Diseases University of Modena and Reggio Emilia Via del Pozzo
More informationCancer Treatments Subcommittee of PTAC Meeting held 2 March 2012. (minutes for web publishing)
Cancer Treatments Subcommittee of PTAC Meeting held 2 March 2012 (minutes for web publishing) Cancer Treatments Subcommittee minutes are published in accordance with the Terms of Reference for the Pharmacology
More informationTreatment of Metastatic Non-Small Cell Lung Cancer: A Systematic Review of Comparative Effectiveness and Cost-Effectiveness
Department of Veterans Affairs Health Services Research & Development Service Treatment of Metastatic Non-Small Cell Lung Cancer: A Systematic Review of Comparative Effectiveness and Cost-Effectiveness
More informationHISTORY OF DEVELOPMENT CURRENT INDICATORS DEVELOPMENT PROSPECTS
HISTORY OF DEVELOPMENT CURRENT INDICATORS DEVELOPMENT PROSPECTS 1. COMPANY DESCRIPTION Biocad is a Russian full cycle biotechnological company. It deals with development, manufacture and promotion of original
More informationWhat is New in Oncology. Michael J Messino, MD Cancer Care of WNC An affiliate of Mission hospitals
What is New in Oncology Michael J Messino, MD Cancer Care of WNC An affiliate of Mission hospitals Personalized Medicine Personalized Genomics Genomic Medicine Precision Medicine Definition Application
More informationSEARCH METHODOLOGY SEARCH STRATEGY #1 (SYSTEMATIC REVIEWS): PubMed 1966-3/16/2012 Cochrane Database of Systematic Reviews All years
Appendix A. Search Strategy for Systematic Reviews and Cost-Effectiveness Analyses (Search #1) TREATMENT OF METASTATIC NON-SMALL-CELL LUNG CANCER SEARCH METHODOLOGY SEARCH STRATEGY #1 (SYSTEMATIC REVIEWS):
More informationRoche Position on Human Stem Cells
Roche Position on Human Stem Cells Background Stem cells and treating diseases. Stem cells and their applications offer an enormous potential for the treatment and even the cure of diseases, along with
More informationThe Cancer Patient Journey. Dr. Jaco Fourie
The Cancer Patient Journey Dr. Jaco Fourie The Cancer Patient Journey Prevention and health promotion Screening Diagnosis and staging Treatment Surveillance and survivorship End of life care The Cancer
More informationBreast. Patient information. cancer clinical pathway
Breast Patient information cancer clinical pathway This leaflet was written to properly inform people following breast cancer treatment plan. It doesn t replace the dialogue with healthcare staff; it rather
More informationPhD Program in Cancer and Immunology
Application Form 2010 APPLICATION DEADLINE: MAY 1ST, 2010 Please print clearly or type APPLICATION (Please, fill in with the name of the thesis director you have chosen from the list provided on our website:
More informationMOH Policy for dispensing NEOPLASTIC DISEASES DRUGS
MOH Policy for dispensing NEOPLASTIC DISEASES DRUGS All prescriptions for antineoplastic drugs must be accompanied by the MOH special form. All the attachments mentioned on this form shall be submitted
More informationMaster in Management. Marianne Snakers
Master in R The of Key success factors A position of excellence through the production of original intellectual work that creates a difference in teaching and expertise, recognized for and by businesses
More informationPRANDELLI CLAUDIO E U R O P E A N PERSONAL INFORMATION WORK EXPERIENCE. 65, Via Caduti di Piazza Loggia, 25030, Urago d'oglio (BS), Italia.
E U R O P E A N C U R R I C U L U M V I T A E F O R M A T PERSONAL INFORMATION Name Address Telephone 3476239691 PRANDELLI CLAUDIO 65, Via Caduti di Piazza Loggia, 25030, Urago d'oglio (BS), Italia. Fax
More informationNuevas tecnologías basadas en biomarcadores para oncología
Nuevas tecnologías basadas en biomarcadores para oncología Simposio ASEBIO 14 de marzo 2013, PCB Jose Jimeno, MD, PhD Co-Founder / Vice Chairman Pangaea Biotech SL Barcelona, Spain PANGAEA BIOTECH BUSINESS
More informationMANCHESTER Lung Cancer Screening Program Dartmouth-Hitchcock Manchester 100 Hitchcock Way Manchester, NH 03104 (603) 695-2850
LEBANON Lung Cancer Screening Program One Medical Center Drive Lebanon, NH 03756 (603) 650-4400 (866) 966-1601 Toll-free cancer.dartmouth.edu/lungscreening MANCHESTER Lung Cancer Screening Program Dartmouth-Hitchcock
More informationRegional Young Investigator SIC meeting. 5-6 March 2015
Regional Young Investigator SIC meeting 5-6 March 2015 Aula Magna A - Università Magna Graecia di Catanzaro - Campus Universitario S. Venuta Viale Europa, loc. Germaneto - Catanzaro Invited speakers: Rita
More informationPharmacogenomic Approaches. Luis Paz-Ares Hospital Universitario Virgen del Rocio Seville, Spain
Pharmacogenomic Approaches Luis Paz-Ares Hospital Universitario Virgen del Rocio Seville, Spain Pharmacogenetics & Pharmacogenomics Medicine tailored to the individual Genetic information, including the
More informationBanking and Finance Graduate Degree
Academic Percorsi Formativi Programs School of Banking, Finance and Insurance Banking and Finance Graduate Degree A Two - Year Graduate Degree www.unicatt.it Milano A.Y. 2014-2015 www.unicatt.it Università
More informationVincenzo Lionetti, M.D., Ph.D.
PERSONAL INFORMATION Vincenzo Lionetti, M.D., Ph.D. Via G. Moruzzi, 1, 56124, +39-050-315-3534 +39-328-0078806 v.lionetti@sssup.it http://www.sssup.it/vincenzo.lionetti Sex Male Date of birth 28/10/1973
More informationSystemic Therapy for Stage IV Non-Small Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
Systemic Therapy for Stage IV Non-Small Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update Introduction The purpose of this guideline update is to revise the 2011
More informationHow To Prepare A Meeting For A Health Care Conference
THORACIC ONCOLOGY MULTIDISCIPLINARY TEAM MEETINGS: OPERATIONAL POLICY EXECUTIVE SUMMARY 1. All patients in Lothian with thoracic malignancies should be discussed at designated times in pathway (see App
More informationNon-small cell lung cancer, advanced or metastatic, switch-therapy after gemcitabine/carboplatin
COMPENDIA TRANSPARENCY TRACKING FORM DRUG: Docetaxel INDICATION: Non-small cell lung cancer, advanced or metastatic, switch-therapy after gemcitabine/carboplatin COMPENDIA TRANSPARENCY REQUIREMENTS 1 Provide
More informationErlotinib for the treatment of non-small cell lung cancer. Report from the Decision Support Unit in response to additional data submitted by Roche
Erlotinib for the treatment of non-small cell lung cancer Report from the Decision Support Unit in response to additional data submitted by Roche 10 th January 2008 Part 1: A Sutton. Critique of the network
More informationMSc in Toxicology. Master Degree Programme
Master Degree Programme MSc in Toxicology Department of Pharmaceutical Sciences, University of Basel Swiss Centre for Applied Human Toxicology (SCAHT) Master of Science in Toxicology University of Basel
More informationLicensure. Registered Pharmacist New York - License number 043093. Certifications. WMD Cardiology ACLS / PALS Pharmacist Immunizer
Danielle Longo, BS, RPh, PharmD 19 Noble Street Lynbrook, NY 11563 Home: 516-887-4998 Cell: 917-922-9550 Fax: 516-887-1110 dlongo@me.com danielle.longo@astrazeneca.com Licensure Certifications Registered
More informationGender Female ; 2 kids (in 2008 and 2010)
Europass Curriculum Vitae Personal information First name(s) / Surname(s) Stefania, Boccia Address(es) 38, Via del Forte Trionfale, 00135, Rome, Italy Telephone(s) +39 (0) 6 35001527 Mobile: +39 347 1227394
More informationNCCN Non-Small Cell Lung Cancer V.1.2011 Update Meeting 07/09/10
Guideline Page and Request NSCL-3 Stage IA, margins positive delete the recommendation for chemoradiation. Stage IB, IIA, margins positive delete the recommendation for chemoradiation + Stage IIA, Stage
More informationEuropass Curriculum Vitae
Europass Curriculum Vitae Personal information First name(s) / Surname(s) Address(es) Chiara Pellacani 10, Via Longarone, IT 20157, Milan (MI), Italy Telephone(s) +39 0239000233 Mobile: +39 3284997822
More informationEmerging Drug List GEFITINIB
Generic (Trade Name): Manufacturer: Gefitinib (Iressa ) formerly referred to as ZD1839 AstraZeneca NO. 52 JANUARY 2004 Indication: Current Regulatory Status: Description: Current Treatment: Cost: Evidence:
More informationName GIRAUDO Donatella Address 26, Via dei Lerda 12100 Cuneo, Italy Telephone + 39 02 26436424 Mobile + 39 3292327764 E-mail giraudo.donatella@hsr.
E UROPEAN CURRICULUM VITAE FORMAT PERSONAL INFORMATION Name GIRAUDO Donatella Address 26, Via dei Lerda 12100 Cuneo, Italy Telephone + 39 02 26436424 Mobile + 39 3292327764 E-mail giraudo.donatella@hsr.it
More informationGroundbreaking Collaborative Clinical Trial Launched
Groundbreaking Collaborative Clinical Trial Launched For immediate release Media Contacts: June 16, 2014 Richard Folkers Alison Hendrie 9:00 a.m., EDT Foundation for the NIH Rubenstein Communications (301)
More informationA clinicians view on NGS of (lung) cancer
A clinicians view on NGS of (lung) cancer oliver.gautschi@onkologie.ch 14.1.2015 Predictive Role of Biomarkers for Lung Cancer Therapy Chemotherapy: not confirmed Anti-Angiogenic-Therapy: not confirmed
More informationGUIDELINES FOR THE MANAGEMENT OF LUNG CANCER
GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER BY Ali Shamseddine, MD (Coordinator); as04@aub.edu.lb Fady Geara, MD Bassem Shabb, MD Ghassan Jamaleddine, MD CLINICAL PRACTICE GUIDELINES FOR THE TREATMENT
More informationBest supportive care: Do we know what it is?
Best supportive care: Do we know what it is? Angela Boland Rumona Dickson Barbara Jack James Stevenson Edge Hill University Faculty of Health www.liv.ac.uk/lrig Collaborative partners Liverpool Reviews
More informationAmel Abd Allah Hashim Ahmed
Amel Abd Allah Hashim Ahmed Lecturer of Biochemistry & Molecular Biology PERSONAL PROFILE Nationality: Egyptian Work: Faculty of Pharmacy, Helwan University, Ain-Helwan, Helwan, Egypt. Work phone: 25590000-
More informationWaiver to Allow Participation in a Food and Drug Administration Advisory Committee
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Silver Spring MD 20993 Waiver to Allow Participation in a Food and Drug Administration Advisory Committee DATE:
More informationE U R O P E A N C U R R I C U L U M V I T A E F O R M A T
E U R O P E A N C U R R I C U L U M V I T A E F O R M A T PERSONAL INFORMATION Name DR. MASSIMILIANO STADERINI Address 180, VIA MURA DEI FRANCESI, 00043 CIAMPINO (ROME) - ITALY - Telephone +39679321109
More informationGenomic Medicine The Future of Cancer Care. Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America
Genomic Medicine The Future of Cancer Care Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America Personalized Medicine Personalized health care is a broad term for interventions
More informationBreast Cancer Drug Discoveries: What the Future Holds
Brochure More information from http://www.researchandmarkets.com/reports/679630/ Breast Cancer Drug Discoveries: What the Future Holds Description: In 2010, almost 50% of breast cancer sales were due to
More informationASCO Initiatives in Personalized Medicine. Richard L. Schilsky, MD, FACP, FASCO Chief Medical Officer American Society of Clinical Oncology
ASCO Initiatives in Personalized Medicine Richard L. Schilsky, MD, FACP, FASCO Chief Medical Officer American Society of Clinical Oncology Financial Disclosures No financial relationships to disclose.
More informationOut-Patient Chemotherapy for Lung Cancer
Lung Cancer Out-Patient Chemotherapy for Lung Cancer Principles and practice JMAJ 46(12): 542 546, 2003 Shuichi YONEDA Director, Department of Pulmonary Medicine, Saitama Cancer Center Abstract: Recent
More informationMetastatic Breast Cancer: RAOM Clinical Practice Guidelines
Russian Association of Oncological Mammology http://www.breastcancersociety.ru/ http://breastcancergroup.net / http://www.bcguidelines.ru/ Clinical recommendations of the Russian Brest Cancer Society for
More informationEstablishing an Advanced Prostate Cancer Clinic: The Rationale
The information, views and opinions expressed in this presentation and any accompanying materials are those of the speaker and do not necessarily reflect the views or position of Cardinal Health or VitalSource.
More informationSAKK Lung Cancer Group. Current activities and future projects
SAKK Lung Cancer Group Current activities and future projects SAKK Lung Cancer Group Open group of physicians interested in lung cancer Mostly Medical Oncologists, but also Thoracic Surgeons Radiation
More informationPrior Authorization Guideline
Prior Authorization Guideline Guideline: PS Inj - Alimta Therapeutic Class: Antineoplastic Agents Therapeutic Sub-Class: Antifolates Client: PS Inj Approval Date: 8/2/2004 Revision Date: 12/5/2006 I. BENEFIT
More informationCourse Curriculum for Master Degree in Clinical Pharmacy
Course Curriculum for Master Degree in Clinical Pharmacy The Master Degree in Clinical Pharmacy is awarded by the Faculty of Graduate studies at Jordan University of Science and Technology (JUST) upon
More informationMasters Learning mode (Форма обучения)
Program Title (Название программы): Pharmacology Degree (Степень) Masters Learning mode (Форма обучения) Full-time and part-time Duration of study (Продолжительность программы) 2 years (4 years part time)
More informationPublic Health and. Interdisciplinary Context. Birgitta Edlund RNT
1 Public Health and Caring Science Nursing Education in an Extended Interdisciplinary Context Birgitta Edlund RNT Associate Professor 2 Uppsala 3 University Main Building 4 Uppsala University Research
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: hematopoietic_stem-cell_transplantation_for_epithelial_ovarian_cancer 2/2001 11/2015 11/2016 11/2015 Description
More informationEducation in Finland
Education in Finland University of Jyväskylä founded in 1934 one of the largest universities in Finland London Berlin total income 176,9 million euros Paris 7 faculties Madrid Rome Athens over 15 700 students
More informationTargeted Therapy What the Surgeon Needs to Know
Targeted Therapy What the Surgeon Needs to Know AATS Focus in Thoracic Surgery 2014 David R. Jones, M.D. Professor & Chief, Thoracic Surgery Memorial Sloan Kettering Cancer Center I have no disclosures
More informationApproval rating: how do the EMA and FDA compare?
Approval rating: how do the EMA and FDA compare? MARC BEISHON When new cancer therapies regularly become available more than half a year earlier in the US than in Europe, or get regulatory approval on
More information1. The conditions for earning a bachelor's degree are that the student must be enrolled for the number of academic
(1) Policy for the Granting of Bachelor's Degrees (Diploma Policy) 1. The conditions for earning a bachelor's degree are that the student must be enrolled for the number of academic years specified by
More informationCurriculum Vitae. Joachim Drevs, MD, PhD. Senior Physician 08/2002 Freiburg/Germany. Head Physician 03/2006 Freiburg/Germany
Curriculum Vitae Joachim Drevs, MD, PhD Private Address Himmelreichstrasse 15 72138 Kirchentellinsfurt Germany Phone: +49 170 1889383 Personal profile marital status: Married, 2 children age: 45 date of
More informationCLINICAL TRIALS SHOULD YOU PARTICIPATE? by Gwen L. Nichols, MD
CLINICAL TRIALS SHOULD YOU PARTICIPATE? by Gwen L. Nichols, MD Gwen L. Nichols, M.D., is currently the Oncology Site Head of the Roche Translational Clinical Research Center at Hoffman- LaRoche. In this
More informationNortheast Ohio Medical University (NEOMED) Chair of Pharmaceutical Sciences Search
Northeast Ohio Medical University (NEOMED) Chair of Pharmaceutical Sciences Search Spring 2013 About NEOMED Northeast Ohio Medical University (NEOMED) www.neomed.edu is a dynamic free-standing community-based,
More informationHow valuable is a cancer therapy? It depends on who you ask.
How valuable is a cancer therapy? It depends on who you ask. Comparing and contrasting the ESMO Magnitude of Clinical Benefit Scale with the ASCO Value Framework in Cancer Ram Subramanian Kevin Schorr
More informationSalisbury Lung Cancer Service (1 of 5)
Salisbury Lung Cancer Service (1 of 5) i If you need this information in another language or medium (audio, large print, etc) please contact Customer Care on 0800 374 208 email: customercare@ salisbury.nhs.uk.
More informationContinuing education for community pharmacists in Denmark the case of Master of Drug Management
Continuing education for community pharmacists in Denmark the case of Master of Drug Management Birthe Søndergaard Associate Professor Department of Pharmacology and Pharmacotherapy, Section of Social
More informationHow To Choose A Pediatric Oncologist
Dr. Geoff Cuvelier MD FRCPC Pediatric Oncologist Dr. Cuvelier is a graduate of the Faculty of Medicine, University of Manitoba, and received undergraduate degrees in microbiology and sociology from the
More informationMaster in Health Services Management
Master in Health Services Management International Centre for Health Management (ICHM) Istituto Superiore di Sanità, Rome In collaboration with Ministry of Foreign Affairs (Italy) Directorate General for
More informationBig Data and Oncology Care Quality Improvement in the United States
Big Data and Oncology Care Quality Improvement in the United States Peter P. Yu, MD, FACP, FASCO President, American Society of Clinical Oncology Director of Cancer Research, Palo Alto Medical Foundation
More informationAdjuvant Therapy Non Small Cell Lung Cancer. Sunil Nagpal MD Director, Thoracic Oncology Jan 30, 2015
Adjuvant Therapy Non Small Cell Lung Cancer Sunil Nagpal MD Director, Thoracic Oncology Jan 30, 2015 No Disclosures Number of studies Studies Per Month 12 10 8 6 4 2 0 1 2 3 4 5 6 7 8 9 10 11 12 1 2 3
More informationREPORT PERSPECTIVES IN LUNG CANCER 2010 AMSTERDAM
REPORT PERSPECTIVES IN LUNG CANCER 2010 AMSTERDAM Valerie Van Damme, Isabelle Wauters, Johan Vansteenkiste Univ. Hospital Leuven and Leuven Lung Cancer Group Introduction Perspectives in Lung Cancer (PILC)
More information